195 related articles for article (PubMed ID: 32102500)
1. LncRNAs as Potential Therapeutic Targets in Thyroid Cancer.
Javed Z; Ahmed Shah F; Rajabi S; Raza Q; Iqbal Z; Ullah M; Ahmad T; Salehi B; Sharifi-Rad M; Pezzani R; Yaqoob F; Sadia H; Iriti M; Sharifi-Rad J; Cho WC
Asian Pac J Cancer Prev; 2020 Feb; 21(2):281-287. PubMed ID: 32102500
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNAs in Thyroid Cancer: Implications for Pathogenesis, Diagnosis, and Therapy.
Mahmoudian-Sani MR; Jalali A; Jamshidi M; Moridi H; Alghasi A; Shojaeian A; Mobini GR
Oncol Res Treat; 2019; 42(3):136-142. PubMed ID: 30799425
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer.
Li Q; Li H; Zhang L; Zhang C; Yan W; Wang C
Oncotarget; 2017 Jul; 8(28):46136-46144. PubMed ID: 28545026
[TBL] [Abstract][Full Text] [Related]
4. Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer.
Zhao Y; Wang H; Wu C; Yan M; Wu H; Wang J; Yang X; Shao Q
Oncol Rep; 2018 Mar; 39(3):1197-1206. PubMed ID: 29328463
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNAs in thyroid cancer: Biological functions and clinical significance.
Sui F; Ji M; Hou P
Mol Cell Endocrinol; 2018 Jul; 469():11-22. PubMed ID: 28751134
[TBL] [Abstract][Full Text] [Related]
6. Targeting Long Non-Coding RNAs in Nervous System Cancers: New Insights in Prognosis, Diagnosis and Therapy.
Malissovas N; Ninou E; Michail A; Politis PK
Curr Med Chem; 2019; 26(30):5649-5663. PubMed ID: 30182849
[TBL] [Abstract][Full Text] [Related]
7. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
[TBL] [Abstract][Full Text] [Related]
8. Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer.
Wang Q; Yang H; Wu L; Yao J; Meng X; Jiang H; Xiao C; Wu F
Thyroid; 2016 Dec; 26(12):1719-1732. PubMed ID: 27758138
[TBL] [Abstract][Full Text] [Related]
9. Targetable long non-coding RNAs in cancer treatments.
Chen L; Dzakah EE; Shan G
Cancer Lett; 2018 Apr; 418():119-124. PubMed ID: 29341880
[TBL] [Abstract][Full Text] [Related]
10. Role of differentially expressed genes and long non-coding RNAs in papillary thyroid carcinoma diagnosis, progression, and prognosis.
Cai WY; Chen X; Chen LP; Li Q; Du XJ; Zhou YY
J Cell Biochem; 2018 Nov; 119(10):8249-8259. PubMed ID: 29968931
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic Properties of the Antisense lncRNA
Esposito R; Esposito D; Pallante P; Fusco A; Ciccodicola A; Costa V
Cancer Res; 2019 May; 79(9):2124-2135. PubMed ID: 30862713
[No Abstract] [Full Text] [Related]
12. The role of long non-coding RNAs in the pathogenesis of thyroid cancer.
Ghafouri-Fard S; Mohammad-Rahimi H; Taheri M
Exp Mol Pathol; 2020 Feb; 112():104332. PubMed ID: 31706987
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNAs: emerging players in thyroid cancer pathogenesis.
Murugan AK; Munirajan AK; Alzahrani AS
Endocr Relat Cancer; 2018 Feb; 25(2):R59-R82. PubMed ID: 29146581
[TBL] [Abstract][Full Text] [Related]
14. LncRNA NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells to cisplatin by sponging miR‑9‑5p and regulating SPAG9 expression.
Yan P; Su Z; Zhang Z; Gao T
Int J Oncol; 2019 Nov; 55(5):988-1002. PubMed ID: 31485599
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma.
Chu YH; Hardin H; Schneider DF; Chen H; Lloyd RV
Exp Mol Pathol; 2017 Oct; 103(2):229-236. PubMed ID: 29107050
[TBL] [Abstract][Full Text] [Related]
16. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic and prognostic significance of long noncoding RNAs expression in thyroid cancer: A systematic review and meta-analysis.
Jing W; Li X; Peng R; Lv S; Zhang Y; Cao Z; Tu J; Ming L
Pathol Res Pract; 2018 Mar; 214(3):327-334. PubMed ID: 29487006
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNAs in thyroid cancer.
Sedaghati M; Kebebew E
Curr Opin Endocrinol Diabetes Obes; 2019 Oct; 26(5):275-281. PubMed ID: 31385810
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.
Niu ZS; Niu XJ; Wang WH
World J Gastroenterol; 2017 Aug; 23(32):5860-5874. PubMed ID: 28932078
[TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication.
Lin YH; Wu MH; Yeh CT; Lin KH
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]